Bellerophon Therapeutics (BLPH) to Offer Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Bellerophon Therapeutics (BLPH) Prices 3.077M Share Common Offering at $13/Sh; Announces Pricing of 1.15M Registered Direct Offering
May 19, 2020 7:04 AM EDTBellerophon Therapeutics, Inc. (NASDAQ: BLPH) today announced the pricing of offerings for an aggregate of 3,076,923 shares of its common stock at a public offering price of $13.00 per share (the Offerings). The Offerings consisted of an underwritten public offering (the Underwritten Offering) of 1,923,077 shares and a registered direct offering (the Direct Offering) of 1,153,846 shares to an institutional investor... More



